Safety and Effectiveness Evaluation of Spinal Laminectomy Robot
A Multicenter, Randomized, Blind Evaluation, Parallel-controlled, Superiority Clinical Trial of Spinal Robot System for Safety and Efficacy Evaluation of Assisted Laminectomy
1 other identifier
interventional
70
1 country
3
Brief Summary
The purpose of this clinical trial is to evaluate the effectiveness and safety of this spinal robot in assisting doctors to perform laminectomy in spinal surgery under the premise of ensuring the safety of the subjects and ensuring the scientific nature of the clinical trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2024
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 9, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedStudy Start
First participant enrolled
October 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2025
CompletedOctober 22, 2024
September 1, 2024
1.2 years
September 9, 2024
October 20, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Accuracy rate of laminectomy
According to the classification criteria for the accuracy of laminectomy proposed by Zhuofu Li, grade A indicates that the pre-planned cutting lines are basically located in the actual cutting groove or that the maximum distance between them is \<1mm; Grade B indicates that the maximum distance between the pre-planned cutting line and the actual cutting groove is 1 to 2mm. Grade C indicates a maximum distance of \>2 mm between the two. Grades A and B are acceptable. The percentage of A+B in the total number of planned boundaries was counted as the accuracy rate of laminectomy.
Immediately after the intraoperative laminectomy procedure
Secondary Outcomes (7)
Success rate of laminectomy
Immediately after the intraoperative laminectomy procedure
Improvement rate of Japanese Orthopaedic Society (JOA) Score
JOA scores were used to evaluate experimental and control subjects before and one month after surgery.
Visual analogue scale (VAS)
Before and one month after the operation
Laminectomy time per spinal segment
Immediately after surgery.
Total laminectomy time
Immediately after surgery.
- +2 more secondary outcomes
Study Arms (2)
Robotic laminectomy group
EXPERIMENTALThe laminectomy is performed with the assistance of a robot
Manual laminectomy group
ACTIVE COMPARATORThe laminectomy is performed by the surgeon without the assistance of a robot
Interventions
Surgical robots are used to assist with laminectomy
Instead of relying on a surgical robot, doctors perform the laminectomy themselves with an ultrasonic osteotome
Eligibility Criteria
You may qualify if:
- Patients aged 18-80 years old (including 18 and 80 years old), regardless of gender;
- Patients with complete clinical data, willing and able to sign informed consent;
- Patients with lumbar disc herniation, lumbar spinal stenosis, lumbar instability, lumbar spondylolisthesis, and lumbar fracture meet the indications for spinal laminectomy and undergoing open surgery;
- Patients with lumbar disc herniation, lumbar spinal stenosis, or lumbar instability have one of the following:
- It was not effective after 3 months of conservative treatment
- Symptoms seriously affect the quality of life
- cauda equina nerve injury
- Lumbar spondylolisthesis occurs in one of the following:
- Symptoms of II° and below slip were not relieved by non-surgical treatment
- Lumbar spondylolisthesis III° and above
- Symptoms of lumbar spinal stenosis
- The TLISS score of lumbar spine fracture is greater than or equal to 4 points.
You may not qualify if:
- Patients who are not suitable for robot-assisted surgery;
- Patients with existing implants in or near the vertebral body of the lesion;
- Patients whose vertebral lamina bone tissue of the focal vertebra or adjacent vertebra has been removed;
- Pregnant and lactating female patients;
- the subject is unwilling or unable to restrict activities or follow medical advice;
- Patients with infection near the focal area;
- The patient is mentally incapable or unable to understand the requirements for participating in the study;
- The patient is critically ill, the expected survival period is not more than 2 years, and it is difficult to make an accurate assessment of the effectiveness and safety of the device;
- Patients with coagulation dysfunction;
- Other researchers did not consider it suitable for admission.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Peking University Third Hospital
Beijing, 100101, China
Third Affiliated hospital of Southern medical university
Guangzhou, China
Zhejiang Provincial Hospital of Chinese Medicine
Hangzhou, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Weishi Li, M.D.
Peking University Third Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 9, 2024
First Posted
September 19, 2024
Study Start
October 15, 2024
Primary Completion
December 30, 2025
Study Completion
December 30, 2025
Last Updated
October 22, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share